All articles by Kalyan Joshi

Kalyan Joshi

November’s top stories: UK fund to tackle malaria, Pfizer to buy Allergan

UK sets up £1bn Ross Fund to tackle malaria, Pfizer agrees to acquire Allergan in $160bn deal, FDA issues complete response letter for BMS’s sBLA for Opdivo. wraps up the key headlines from November 2015.

October’s top stories: Clinical trial to test aspirin, treatment for liposarcoma

FDA grants breakthrough status for Pfizer’s leukaemia drug inotuzumab ozogamicin, Alkermes’s Aristada gets FDA approval to treat schizophrenia, Domainex and Imperial to discover new therapies for myocardial infarction. wraps up the key headlines from October 2015.